StairMed’s last round was in 2023, when it raised “hundreds of millions of yuan”. Lilly Asia Ventures praised StairMed as a “global leader” in “flexible electrode technology and full ...

Pulnovo Medical announced yesterday that it closed a Series C funding round worth proceeds of nearly $100 million.

Pulnovo Medical has closed a Series C financing round, securing around $100m for progressing the company's worldwide trials, ...

Shanghai StairMed Technology has secured 350 million yuan ($48.3 million) in a Series B funding round led by several ...

Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This ...

Pulnovo Medical, a developer of medical devices for pulmonary hypertension and heart failure, has closed its oversubscribed Series C funding round at nearly $100 million to advance global clinical ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The latest funding round was led by Qiming Venture Partners, OrbiMed and Lilly Asia Ventures, with previous angel investor FountainBridge Capital also participating. StairMed had previously ...

Seed and first-round funding came from 5AM Ventures, Binney Street Capital, Lilly Asia Ventures, Illumina Ventures, Bristol Myers Squibb, Osage University Partners, and Qatar Investment Authority.

along with existing backers Lilly Asia Ventures (LAV) and LYFE Capital. Finally, Firefly Bio emerged from stealth mode with a $94 million Series A financing – co-led by Versant Ventures and by ...